SCHEMBL7183451

SCHEMBL7183451

CCCc1ccc(OCC)c(/C=C/C(=O)c2ccc(N)cc2)c1OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 5/20 0.44
CYP1A1 P04798 4/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2D6 P10635 3/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
KRAS P01116 1/20 0.44
MAPT P10636 5/20 0.42
LMNA P02545 5/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ATM Q13315 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAOB P27338 4/20 0.40
MAOA P21397 1/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7183455 1.00 CYP1B1 (0.44) CYP1B1CYP1A1CYP1A2CYP2D6CA1
SCHEMBL7181412 0.90 CA1 (0.43) CYP1B1CYP1A1CA1CA2KRAS
SCHEMBL7187702 0.90 ABCG2 (0.51) CYP1B1CYP1A1CYP1A2CYP2D6MAPT
SCHEMBL7187705 0.90 ABCG2 (0.51) CYP1B1CYP1A1CYP1A2CYP2D6MAPT
SCHEMBL7178891 0.89 ABCG2 (0.44) CYP1B1CYP1A2CA1CA2KRAS
SCHEMBL7177791 0.87 CYP1A1 (0.42) CYP1B1CYP1A1CYP1A2CYP2D6MAPT
SCHEMBL7184677 0.87 MAPT (0.44) CYP1B1CYP1A1CYP1A2CYP2D6MAPT
SCHEMBL7184673 0.87 MAPT (0.44) CYP1B1CYP1A1CYP1A2CYP2D6MAPT
SCHEMBL7177798 0.87 CYP1A1 (0.42) CYP1B1CYP1A1CYP1A2CYP2D6MAPT
SCHEMBL7191820 0.87 PTPN1 (0.47) CYP1B1CYP1A1CYP1A2CYP2D6CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed